An innovation-led, contract research, development & manufacturing organization offering integrated scientific services from early discovery to commercial supply
Syngene is delighted to share that we are part of Fortune India’s Top 100 Wealth Creators list for 2021.
The criteria involved being a listed company with a 5-year CAGR of 7.5% plus in terms of market cap, revenue &profit (2017-21).
#FortuneIndia
#Syngene
#FortuneList
#CDMO
1/5
Congratulations to the entire
@Bioconlimited
team for this great achievement of receiving approval from
#DCGI
for use of its drug in treating
#COVID19
patients (with moderate to severe symptoms). Proud to be part of the
#Biocon
group’s efforts to combat COVID-19 in India.
#ProudToShare
:
#Biocon
’s Breakthrough Drug
#Itolizumab
Receives DCGI Nod for its Use in Moderate to Severe
#COVID19
Patients, the first novel biologic therapy to be approved by DCGI for treating patients with moderate to severe COVID-19 complications.
Whether it is discovering
#antibodies
in a lab or scaling the world’s highest peaks, she does both with equal élan!
Priyanka Mohite of
#Syngene
, recently created history by becoming the
#first_Indian_woman
to scale Mt
#Annapurna
-I, the 10th highest
#mountain
in the world.
(1/6)
We are delighted to share that Syngene has extended its ongoing long-standing multi-discipline research collaboration with
#Amgen
Inc until 2026.
(1/3)
We are happy to share US Food & Drug Administration (FDA) conducted its pre-approval inspection of
#Biologics
facility at Bangalore in Nov2022. The inspection was completed successfully without 483 observations.
Congrats to our team members who achieved this fantastic result!
1/2
Happy to have a partnership with Syngene
@kiranshaw
, to make Mylab's COVID-19 test kit more indigenous; reducing its dependency on international raw materials and to further strengthen India’s self-reliance in response to
#Covid_19
#MakeInIndia
@SyngeneIntl
@MylabSolutions
Our facility comes with a dedicated purification lab, photoredox & electrochemistry capabilities. It also has analytical labs with server-based software for all instruments to enable
#scientists
to work in labs remotely, if required.
Know more 👉.
#PROTACs
#TomCruise
returns with a bang in
#MissionImpossible
- Dead Reckoning Part 1! As Ethan Hunt, he battles formidable foes, racing to save the day. Meanwhile,
#biotech
&
#pharma
companies are taking on their own impossible missions to save lives worldwide. Watch now to learn more!
We are delighted to share that Syngene has signed an MoU with Jananom. Jananom is an India-based institution providing synthetic biology & biomolecular engineering services. It is accredited by the Department of Science & Industrial Research, Gov. of India
@DrMaheshBhalgat
1/3
Syngene is collaborating with a US-based client to discover a first-in-class drug for fibrotic disorders as part of an Integrated Drug Discovery (IDD) program.
(1/6)
#drugdiscovery
#fibrosis
#Client
#USA
Ever wondered how
#COVID19
RT-PCR testing is done. Here’s a short explanation. Our recently opened COVID-19 testing lab works with local hospitals to expand the testing capability in Bengaluru. Click to watch.
@kiranshaw
@DrMaheshBhalgat
#Covid19testing
Watch now! Our MD & CEO, Jonathan Hunt shares his perspective on the Q2FY23
#financialresults
.👉
He covers:
⦿Syngene's performance in first half of the year
⦿Syngene – Zoetis collaboration over the years & details of the recent 10-year deal
#ceospeaks
1/2
#Syngene
has successfully delivered on multiple
#HPAPI
molecules for its global clientele. We offer integrated solutions for high potent
#molecules
from Discovery, Development & Clinical supplies to Commercialization.
For more info pls write to bdc
@syngeneintl
.com
#BioPharma
#CRO
Despite a challenging year, we added 40 new clients & reported revenue growth, excluding export incentives, of 12% to ₹21,802 Mn ($295 Mn) & PAT growth of 4% to ₹3,821 Mn ($52 Mn).
Read full
#AnnualReport
here👉.
#Syngene
#CDMO
#CRO
#Biopharma
#USA
Only 3 days left to connect with our team on the event platform to discuss how we can assist you in advancing your
#Biologics
programs. We offer services across Mammalian & Microbial Systems including
#GMP
manufacturing. Email us at bdc
@syngeneintl
.com
#BIODigital
#largemolecules
Pleased to share that the
#Biocon
Group of Companies inaugurated a
#VaccinationCentre
in Syngene’s Bengaluru campus as part of the nationwide drive for mass vaccination of people above 45 years of age to protect them from
#COVID19
.
Read now 👉
#PressRelease
Q3 revenue growth was driven by a sustained performance from all divisions. Continued focus on cost control measures and improving operational efficiency have underpinned profitability & delivered a strong profit margin. Know more
#Q3FY21
#Pressrelease
We are now ready for commercial supplies of solid orals (for human consumption) of formulation/finished dosage form to the
#Russian
market. We have been
#GMP
certified by
#USFDA
since 2018. Write to us at bdc
@syngeneintl
.com for any
#FormulationDevelopment
related queries.
We are delighted to share that another premier
#creditrating
agency in
#India
,
#ICRA
, has upgraded our long-term credit rating from AA/Positive to AA+/Stable. Earlier,
#CRISIL
had also upgraded our long-term credit rating from AA/Positive outlook to AA+/Stable outlook.
#Syngene
Syngene has the capability to partner with RT-PCR diagnostic kit providers for kit development and high-quality reagent supply - primers, probes, S-protein and N-protein. Contact us at bdc
@syngeneintl
.com to know more.
@DrMaheshBhalgat
#COVID19
Immuno-oncology being a key focus area for Syngene, we r pleased 2 be partnering with
@repositiveio
which has world’s largest directory of preclinical
#cancer
models. This partnership will help us expand our network 2 reach more clients & assist in developing innovative therapies
We're excited to announce a new addition to our network of CRO partners:
@SyngeneIntl
, an internationally reputed CDMO based in India, with experience in setting up diverse efficacy cancer models and screening new chemical entities (NCEs).
Read more here:
Congratulations on your achievement 👏👏!
#Bylvay
(odevixibat) is indeed a much-needed drug for a rare disorder affecting young children that causes progressive, life-threatening liver disease.
#rarediseases
#PFCI
#odevixibat
We helped the client drive one TPD program till the candidate delivery stage & advanced many programs to the lead optimization stage. We delivered
#PROTAC
degraders up to a 3.0g scale for advanced
#PKstudies
.
Know more👉 or email us 👉 bdc
@syngeneintl
.com
Delighted to share that the Dept. of Scientific and Industrial Research (DSIR) has granted recognition to two of our new R&D units in Bengaluru and Hyderabad. With this, all R&D facilities of Syngene are now approved/recognized by
#DSIR
.
Know more👉
The company plans to hire 25-30% more scientists this year to ensure a continuous inflow of talent including hiring from international markets if required, Biswas said.
To read the full interview, click👉
#finance
#syngene
#cfoinsights
#CFO
#CDMO
#CRO
We have plans for
#Hyderabad
!
What a better stage to announce our arrival to HYD than one of the biggest
#BioPharma
forums in Asia-
@BioAsiaOfficial
. Our heartfelt thanks to
@KTRTRS
for unveiling the ceremonial plaque. Also seen
@kiranshaw
and other delegates. Thank you all :)
We are delighted to share that we have won the
#Asian_Leadership_Award
for Excellence in Branding & Marketing in the CRO/CDMO space. The
#Award
is in recognition of our commitment, best practices & innovative strategies, resulting in business growth.
#CDMO
#CRDMO
#Leadershipaward
Our first CRO spotlight post is live, featuring
@SyngeneIntl
, a leading global CRO/CDMO with extensive skills in setting up diverse efficacy cancer models and screening NCEs. To read more about the models & services they offer, click here: .
#CRO
#partner
What does it take to become a
#scientist
? Passion for science, perseverance & compassion for humanity – the values
#Syngene
lives by.
@Soyab14Ansari
from Syngene, did us proud recently, when in addition to his passion for science, he displayed passion for a cause.
#cyclists
#Syngene
successfully fast-tracked the generation of the
#SARS_CoV_2
reagent proteins for use in
#diagnostic
kits and novel antibody/
#vaccine
research. Our high-quality
#proteins
are currently being used by organizations across the globe. Know more .
We are proud to share that our founder and Non-Executive Chairperson
@kiranshaw
has been recognized as one of the ‘60 Biopharma pioneers over 60 who helped birth a tech revolution in the making’ by Endpoints News.
Hearty Congratulations Kiran! We are proud of your achievements.
We are delighted to share that Syngene’s boiler from its
#APImanufacturing
facility, Mangalore, was adjudged ‘The Best Package
#Boiler
’ in Karnataka.
To discuss your API manufacturing needs with our experts, book a meeting now👉.
#NationalSafetyweek
#CDMO
#Ugadi
is celebrated majorly in most southern states of India, while
#GudiPadwa
is celebrated in Maharashtra & Goa. It marks the beginning of the new year as per the traditional calendars.
May this festival of new beginnings bring happiness, good health & prosperity to all.
Pleased to share that
#Syngene
has commissioned a new microbial
#cGMP
facility & also expanded the capacity of its
#mammalian
cell manufacturing facility to extend end2end Chemistry & CMC solutions for its global clients.
Read
#Press_Release
👉.
#biopharma
On the occasion of
#World_Environment_Day
,
#Syngene
reaffirms its commitment to operating
#sustainably
while delivering benefits to our stakeholders and wider society. Here are the various ways in which we are doing our bit to preserve
#biodiversity
for future generations.
(1/4)
We are proud to share that Syngene was ranked top in the CMO Leadership Awards 2022. Syngene received 6 awards across all categories including Capabilities, Compatibility, Expertise, Quality, Reliability and Service.
(1/2)
#awards2022
#BioPharma
Ugadi, marks the beginning of a New Year in the southern states of India & Maharashtra & observed on April 13. The rest of India celebrates New Year on April 14 & 15. On this auspicious occasion, we wish everyone a bright & happy 2021.
#festivals
#India
#Ugadi
#Vishu
#GudiPadwa
#USFDA
successfully conducted clinical Bioresearch Monitoring (BIMO) inspection at our Human Pharmacology Unit facility with ZERO observations. This result reinforces our commitment to delivering our services with the highest regard for
#Safety
,
#Quality
&
#RegulatoryCompliance
.
Targeted Protein Degradation(TPD) is fast emerging as one of the most promising approaches to selectively target, previously undruggable proteins. To know about Syngene's services in PROTACs, please click 👉
#drugdiscovery
#PROTACs
In association with the group
#CSR
arm,
@Biocon_FDN
, a science fair for
#schoolchildren
& a
#health
camp for the elderly were held in our local communities in
#Bangalore
as a tribute to the late John Shaw, former vice chairman of Biocon & former board member of Syngene.
Happy to share, Syngene was conferred with the award for ‘Best Governed Company in the Listed Segment: Medium Category’ at the 21st National Awards for Excellence in
#CorporateGovernance
by the Institute of Company Secretaries of India.
(1/3)
Over the last 15 years, our lab has supported clinical programs of more than 50
#biotherapeutics
for submission to
#FDA
& EMA, including 3 blockbuster drugs. We have also analysed 600,000+ samples received from around the globe.
Book a meeting now👉.
Team Syngene wishes you and your family a very Happy
#GaneshChaturthi
. May Lord
#Ganesha
, the Vignaharatha, rid this world of disease, pain and suffering & fill it with good health, joy & prosperity.
Ganapati Bappa Morya. Mangalmurti Morya!
#VinayakaChavithi
#India
#Syngene
Watch now! Our
#CFO
, Sibaji Biswas shares his perspective about the Q2FY23
#financialresults
.
👉
He covers
⦿ Syngene’s performance in the first half of the year
⦿ Highlights in the first two-quarters of FY23
⦿ Other focus areas for Syngene
#cfospeaks
We are happy to share Syngene’s Bangalore sites were successfully audited for ISO-14001 & ISO-45001 certification - Integrated Environment & Human Health, Safety & Security (EHSS) management systems by TuV Nord. The audit was conducted earlier this month (Nov 7-11, 2022).
1/2
Are you attending the Drug Discovery Chemistry event between May 18 and May 20? Then, don't miss our colleague, Dr Santosh Kulkarni's talk on ‘RNA-targeted small molecule discovery’! To book a meeting or know more, write to bdc
@syngeneintl
.com
#drugdiscoverychemistry
#syngene
#Syngene
offers various animal models for NASH, for studying pathophysiology & various treatment interventions.
To request pricing details or know more about our
#NASHmodels
in terms of study design, test groups or primary readouts, click .
#Biopharma
#CRO
We provide scientific and engineering solutions for Performance & Specialty Materials to enhance the properties of
#polymers
,
#biomaterials
, functional materials, specialized
#monomers
&
#smallmolecules
.
Click👉 to know more or to book a meeting.
#Syngene
Syngene has signed an MoU with
@CCAMP_Bangalore
an initiative supported by the Department of Biotechnology, Govt of India, located in Bangalore. C-CAMP facilitates bioscience
#research
& innovation by providing R&D & training services.
@DrMaheshBhalgat
, Dr
@Taslimarif
1/2
We recently hosted
@iiscbangalore
faculty members at our Bangalore campus as part of our initiative to exchange ideas & expertise with top
#research
#institutes
. They were offered an extensive tour of our campus to catch a glimpse of Syngene's capabilities & facilities.
1/2
#Syngene
has successfully delivered on multiple
#HPAPI
molecules for its global clientele. We offer integrated solutions for high potent
#molecules
from Discovery, Development & Clinical supplies to Commercialization.
For more info pls write to bdc
@syngeneintl
.com
#BioPharma
#CRO
Read what our MD & CEO, Jonathan Hunt had to say on ‘What sets Syngene apart in the competitive CRAMS (Custom Research And Manufacturing Services) space and the road ahead.'
Click 👉 to read the full interview.
#MediaCoverage
(1/4)
On the auspicious occasion of the
#Harvestfestival
, let us seek the blessings of the Sun God for a successful vaccination drive --across the nation & the world.
May the year 2021, be the year of recovery & prosperity for all. Team Syngene
#sankrantiwishes
#HappySankranti
#India
We are delighted to share that our client
#Panbela
has received an Issue Notification for
#patent
US 11,098,005 titled “Methods of producing (6S,15S)-3,8,13,18-Tetraazaicosane-6,15-diol” meant for treating
#pancreaticcancer
.
Read press release👉
#biopharma